Targeted Rapid Endotoxin Adsorption: Can We Bring Precision Medicine to Sepsis?

2.

Abel

JJ

,

Rowntree

LG

,

Turner

BB

.

On the removal of diffusable substances from the circulating blood by means of dialysis. Transactions of the Association of American Physicians, 1913

.

Transfus Sci

.

1990

;

11

(

2

):

164

–

5

.

3.

Ghannoum

M

,

Nolin

TD

,

Lavergne

V

,

Hoffman

RS

,

EXTRIP workgroup

.

Blood purification in toxicology: nephrology's ugly duckling

.

Adv Chronic Kidney Dis

.

2011

;

18

(

3

):

160

–

6

.

4.

Schreiner

GE

.

The role of hemodialysis (artificial kidney) in acute poisoning

.

AMA Arch Intern Med

.

1958

;

102

(

6

):

896

–

913

.

5.

Yatzidis

H

.

[Research on extrarenal purification with the aid of activated charcoal]

.

Nephron

.

1964

;

1

:

310

–

2

.

6.

Stein

B

,

Pfenninger

E

,

Grünert

A

,

Schmitz

JE

,

Hudde

M

.

Influence of continuous haemofiltration on haemodynamics and central blood volume in experimental endotoxic shock

.

Intensive Care Med

.

1990

;

16

(

8

):

494

–

9

.

7.

Bellomo

R

,

Tipping

P

,

Boyce

N

.

Tumor necrosis factor clearances during veno-venous hemodiafiltration in the critically ill

.

ASAIO Trans

.

1991

;

37

(

3

):

M322

–

323

.

8.

Gomez

A

,

Wang

R

,

Unruh

H

,

Light

RB

,

Bose

D

,

Chau

T

, et al.

Hemofiltration reverses left ventricular dysfunction during sepsis in dogs

.

Anesthesiology

.

1990

;

73

(

4

):

671

–

85

.

9.

Grootendorst

AF

,

van Bommel

EF

,

van der Hoven

B

,

van Leengoed

LA

,

van Osta

AL

.

High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig

.

Intensive Care Med

.

1992

;

18

(

4

):

235

–

40

.

10.

Gotloib

L

,

Barzilay

E

,

Shustak

A

,

Wais

Z

,

Jaichenko

J

,

Lev

A

.

Hemofiltration in septic ARDS. The artificial kidney as an artificial endocrine lung

.

Resuscitation

.

1986

;

13

(

2

):

123

–

32

.

11.

Stein

B

,

Pfenninger

E

,

Grünert

A

,

Schmitz

JE

,

Deller

A

,

Kocher

F

.

The consequences of continuous haemofiltration on lung mechanics and extravascular lung water in a porcine endotoxic shock model

.

Intensive Care Med

.

1991

;

17

(

5

):

293

–

8

.

12.

Ossenkoppele

GJ

,

van der Meulen

J

,

Bronsveld

W

,

Thijs

LG

.

Continuous arteriovenous hemofiltration as an adjunctive therapy for septic shock

.

Crit Care Med

.

1985

;

13

(

2

):

102

–

4

.

13.

Lau

AH

,

Pyle

K

,

Kronfol

NO

,

Libertin

CR

.

Removal of cephalosporins by continuous arteriovenous ultrafiltration (CAVU) and hemofiltration (CAVH)

.

Int J Artif Organs

.

1989

;

12

(

6

):

379

–

83

.

14.

Connelly-Smith

L

,

Alquist

CR

,

Aqui

NA

,

Hofmann

JC

,

Klingel

R

,

Onwuemene

OA

, et al.

Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the writing committee of the American society for apheresis: the ninth special issue

.

J Clin Apher

.

2023

;

38

(

2

):

77

–

278

.

15.

Kellum

JA

,

Ronco

C

.

The role of endotoxin in septic shock

.

Crit Care

.

2023

;

27

(

1

):

400

.

16.

Kashani

K

,

Forni

LG

.

Extracorporeal blood purification is appropriate in critically ill patients with COVID-19 and multiorgan failure: CON

.

Kidney360

.

2022

;

3

(

3

):

419

–

22

.

17.

Venkataraman

R

,

Subramanian

S

,

Kellum

JA

.

Clinical review: extracorporeal blood purification in severe sepsis

.

Crit Care

.

2003

;

7

(

2

):

139

–

45

.

18.

Kellum

JA

,

Kong

L

,

Fink

MP

,

Weissfeld

LA

,

Yealy

DM

,

Pinsky

MR

, et al.

Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the genetic and inflammatory markers of sepsis (GenIMS) study

.

Arch Intern Med

.

2007

;

167

(

15

):

1655

–

63

.

19.

Barzilay

E

,

Kessler

D

,

Berlot

G

,

Gullo

A

,

Geber

D

,

Ben Zeev

I

.

Use of extracorporeal supportive techniques as additional treatment for septic-induced multiple organ failure patients

.

Crit Care Med

.

1989

;

17

(

7

):

634

–

7

.

20.

Evans

L

,

Rhodes

A

,

Alhazzani

W

,

Antonelli

M

,

Coopersmith

CM

,

French

C

, et al.

Surviving sepsis Campaign: international guidelines for management of sepsis and septic shock 2021

.

Crit Care Med

.

2021

;

49

(

11

):

e1063

–

143

.

21.

Menne

J

,

Nitschke

M

,

Stingele

R

,

Abu-Tair

M

,

Beneke

J

,

Bramstedt

J

, et al.

Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study

.

BMJ

.

2012

;

345

:

e4565

.

22.

Kellum

JA

,

Song

M

,

Venkataraman

R

.

Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kappaB DNA binding, and improves short-term survival in lethal endotoxemia

.

Crit Care Med

.

2004

;

32

(

3

):

801

–

5

.

23.

Peng

ZY

,

Carter

MJ

,

Kellum

JA

.

Effects of hemoadsorption on cytokine removal and short-term survival in septic rats

.

Crit Care Med

.

2008

;

36

(

5

):

1573

–

7

.

24.

Peng

ZY

,

Bishop

JV

,

Wen

XY

,

Elder

MM

,

Zhou

F

,

Chuasuwan

A

, et al.

Modulation of chemokine gradients by apheresis redirects leukocyte trafficking to different compartments during sepsis, studies in a rat model

.

Crit Care

.

2014

;

18

(

4

):

R141

.

25.

Peng

ZY

,

Wang

HZ

,

Carter

MJ

,

Dileo

MV

,

Bishop

JV

,

Zhou

FH

, et al.

Acute removal of common sepsis mediators does not explain the effects of extracorporeal blood purification in experimental sepsis

.

Kidney Int

.

2012

;

81

(

4

):

363

–

9

.

26.

Namas

RA

,

Namas

R

,

Lagoa

C

,

Barclay

D

,

Mi

Q

,

Zamora

R

, et al.

Hemoadsorption reprograms inflammation in experimental gram-negative septic peritonitis: insights from in vivo and in silico studies

.

Mol Med

.

2012

;

18

(

1

):

1366

–

74

.

27.

Becker

S

,

Lang

H

,

Vollmer Barbosa

C

,

Tian

Z

,

Melk

A

,

Schmidt

BMW

.

Efficacy of CytoSorb®: a systematic review and meta-analysis

.

Crit Care

.

2023

;

27

(

1

):

215

.

28.

Kellum

JA

,

Pike

F

,

Yealy

DM

,

Huang

DT

,

Shapiro

NI

,

Angus

DC

, et al.

And the protocol-based care for early septic shock investigators I: relationship between alternative resuscitation strategies, host response and injury biomarkers, and outcome in septic shock: analysis of the protocol-based care for early septic shock study

.

Crit Care Med

.

2017

;

45

(

3

):

438

–

45

.

29.

Gupta

S

,

Sakhuja

A

,

Kumar

G

,

McGrath

E

,

Nanchal

RS

,

Kashani

KB

.

Culture-negative severe sepsis: nationwide trends and outcomes

.

Chest

.

2016

;

150

(

6

):

1251

–

9

.

30.

Silver

SM

.

Cerebral edema after rapid dialysis is not caused by an increase in brain organic osmolytes

.

J Am Soc Nephrol

.

1995

;

6

(

6

):

1600

–

6

.

31.

Bellomo

R

,

Ankawi

G

,

Bagshaw

SM

,

Baldwin

I

,

Basu

R

,

Bottari

G

, et al.

Hemoadsorption: consensus report of the 30th acute disease quality initiative workgroup

.

Nephrol Dial Transplant

.

2024

;

39

(

12

):

1945

–

64

.

32.

Angus

DC

,

van der Poll

T

.

van der Poll T: Severe sepsis and septic shock

.

N Engl J Med

.

2013

;

369

(

9

):

840

–

51

.

33.

Brinkworth

JF

,

Valizadegan

N

.

Sepsis and the evolution of human increased sensitivity to lipopolysaccharide

.

Evol Anthropol

.

2021

;

30

(

2

):

141

–

57

.

34.

Adamik

B

,

Smiechowicz

J

,

Jakubczyk

D

,

Kübler

A

.

Elevated serum PCT in septic shock with endotoxemia is associated with a higher mortality rate

.

Medicine

.

2015

;

94

(

27

):

e1085

.

35.

Dellinger

RP

,

Bagshaw

SM

,

Antonelli

M

,

Foster

DM

,

Klein

DJ

,

Marshall

JC

, et al.

Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES randomized clinical trial

.

JAMA

.

2018

;

320

(

14

):

1455

–

63

.

36.

Sirivongrangson

P

,

Kulvichit

W

,

Payungporn

S

,

Pisitkun

T

,

Chindamporn

A

,

Peerapornratana

S

, et al.

Endotoxemia and circulating bacteriome in severe COVID-19 patients

.

Intensive Care Med Exp

.

2020

;

8

(

1

):

72

.

37.

van Lier

D

,

Geven

C

,

Leijte

GP

,

Pickkers

P

.

Experimental human endotoxemia as a model of systemic inflammation

.

Biochimie

.

2019

;

159

:

99

–

106

.

38.

Taveira da Silva

AM

,

Kaulbach

HC

,

Chuidian

FS

,

Lambert

DR

,

Suffredini

AF

,

Danner

RL

.

Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin

.

N Engl J Med

.

1993

;

328

(

20

):

1457

–

60

.

39.

Molteni

M

,

Gemma

S

,

Rossetti

C

.

The role of toll-like receptor 4 in infectious and noninfectious inflammation

.

Mediators Inflamm

.

2016

;

2016

:

6978936

.

40.

Marshall

JC

,

Foster

D

,

Vincent

JL

,

Cook

DJ

,

Cohen

J

,

Dellinger

RP

, et al.

Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study

.

J Infect Dis

.

2004

;

190

(

3

):

527

–

34

.

41.

Ikeda

T

,

Ikeda

K

,

Suda

S

,

Ueno

T

.

Usefulness of the endotoxin activity assay as a biomarker to assess the severity of endotoxemia in critically ill patients

.

Innate Immun

.

2014

;

20

(

8

):

881

–

7

.

42.

Romaschin

AD

,

Obiezu-Forster

CV

,

Shoji

H

,

Klein

DJ

.

Novel insights into the direct removal of endotoxin by polymyxin B hemoperfusion

.

Blood Purif

.

2017

;

44

(

3

):

193

–

7

.

43.

Kellum

JA

,

Formeck

CL

,

Kernan

KF

,

Gómez

H

,

Carcillo

JA

.

Subtypes and mimics of sepsis

.

Crit Care Clin

.

2022

;

38

(

2

):

195

–

211

.

44.

Cutuli

SL

,

De Rosa

S

,

Ferrer

R

,

Ruiz-Rodriguez

JC

,

Forfori

F

,

Ronco

C

, et al.

Endotoxin activity trend and multi-organ dysfunction in critically ill patients with septic shock, who received Polymyxin-B hemadsorption: a multicenter, prospective, observational study

.

Artif Organs

.

2023

;

47

(

8

):

1361

–

70

.

45.

Fujimori

K

,

Tarasawa

K

,

Fushimi

K

.

Effectiveness of polymyxin B hemoperfusion for sepsis depends on the baseline SOFA score: a nationwide observational study

.

Ann Intensive Care

.

2021

;

11

(

1

):

141

.

46.

Asanuma

Y

,

Takahashi

T

,

Kato

T

,

Kudo

K

,

Koyama

K

.

[Treatment of endotoxin shock due to gram-negative bacteremia using extracorporeal circulation

.

Nihon Shokakibyo Gakkai Zasshi

.

1989

;

86

(

2

):

246

–

52

.

47.

Hanasawa

K

,

Tani

T

,

Oka

T

,

Yoshioka

T

,

Aoki

H

,

Endo

Y

, et al.

Selective removal of endotoxin from the blood by extracorporeal hemoperfusion with polymyxin B immobilized fiber

.

Prog Clin Biol Res

.

1988

;

264

:

337

–

41

.

48.

Kellum

JA

,

Dishart

MK

.

Effect of hemofiltration filter adsorption on circulating IL-6 levels in septic rats

.

Crit Care

.

2002

;

6

(

5

):

429

–

33

.

49.

Clark

WR

,

Ferrari

F

,

La Manna

G

,

Ronco

C

.

Extracorporeal sorbent technologies: basic concepts and clinical application

.

Contrib Nephrol

.

2017

;

190

:

43

–

57

.

50.

Liu

TY

,

Lin

WC

,

Huang

LY

,

Chen

SY

,

Yang

MC

.

Hemocompatibility and anaphylatoxin formation of protein-immobilizing polyacrylonitrile hemodialysis membrane

.

Biomaterials

.

2005

;

26

(

12

):

1437

–

44

.

51.

Weber

M

,

Steinle

H

,

Golombek

S

,

Hann

L

,

Schlensak

C

,

Wendel

HP

, et al.

Blood-contacting biomaterials: in vitro evaluation of the hemocompatibility

.

Front Bioeng Biotechnol

.

2018

;

6

:

99

.

52.

Ullrich

H

,

Jakob

W

,

Fröhlich

D

,

Rothe

G

,

Prasser

C

,

Drobnik

W

, et al.

A new endotoxin adsorber: first clinical application

.

Ther Apher

.

2001

;

5

(

5

):

326

–

34

.

53.

Reinhart

K

,

Meier-Hellmann

A

,

Beale

R

,

Forst

H

,

Boehm

D

,

Willatts

S

, et al.

Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected Gram-negative sepsis

.

Crit Care Med

.

2004

;

32

(

8

):

1662

–

8

.

54.

Fujimori

K

,

Tarasawa

K

,

Fushimi

K

.

Effects of polymyxin B hemoperfusion on septic shock patients requiring noradrenaline: analysis of a nationwide administrative database in Japan

.

Blood Purif

.

2021

;

50

(

4–5

):

560

–

5

.

55.

Malard

B

,

Lambert

C

,

Kellum

JA

.

In vitro comparison of the adsorption of inflammatory mediators by blood purification devices

.

Intensive Care Med Exp

.

2018

;

6

(

1

):

12

.

56.

Gendel

LL

,

Sokolov

АА

,

Gubаnovа

SN

,

Аdаmovа

IY

,

Levаshov

PА

.

First clinical Experience of using column for LPS-adsorption of Toxipak in treatment of sepsis patients

.

MAaR

.

2017

;

14

(

5

):

42

–

50

.

57.

Sokolov Aag

SN

,

Popov

AV

.

LPS adsorption with Toxipak columns in treatment of sepsis

.

12th world congress of international society for Apheresis: 2019

.

Kyoto

;

2019

. p.

PP6

–

01

.

58.

Lipcsey

M

,

Tenhunen

J

,

Pischke

SE

,

Kuitunen

A

,

Flaatten

H

,

De Geer

L

, et al.

Endotoxin removal in septic shock with the Alteco LPS adsorber was safe but showed no benefit compared to placebo in the double-blind randomized controlled trial-the asset study

.

Shock

.

2020

;

54

(

2

):

224

–

31

.

59.

Staubach

KH

,

Boehme

M

,

Zimmermann

M

,

Otto

V

.

A new endotoxin adsorption device in Gram-negative sepsis: use of immobilized albumin with the MATISSE adsorber

.

Transfus Apher Sci

.

2003

;

29

(

1

):

93

–

8

.

60.

Shoji

H

,

Tani

T

,

Hanasawa

K

,

Kodama

M

.

Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and antiendotoxin efficacy in the clinical application

.

Ther Apher

.

1998

;

2

(

1

):

3

–

12

.

61.

Foster

DM

,

Kellum

JA

.

Endotoxic septic shock: Diagnosis and treatment

.

Int J Mol Sci

.

2023

;

24

(

22

):

16185

.

62.

Cruz

DN

,

Antonelli

M

,

Fumagalli

R

,

Foltran

F

,

Brienza

N

,

Donati

A

, et al.

Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial

.

JAMA

.

2009

;

301

(

23

):

2445

–

52

.

63.

Payen

DM

,

Guilhot

J

,

Launey

Y

,

Lukaszewicz

AC

,

Kaaki

M

,

Veber

B

, et al.

Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial

.

Intensive Care Med

.

2015

;

41

(

6

):

975

–

84

.

64.

Payen

D

,

Dupuis

C

,

Deckert

V

,

Pais de Barros

JP

,

Rérole

AL

,

Lukaszewicz

AC

, et al.

Endotoxin mass concentration in plasma is associated with mortality in a multicentric cohort of peritonitis-induced shock

.

Front Med

.

2021

;

8

:

749405

.

65.

Dargent

A

,

Pais De Barros

JP

,

Ksiazek

E

,

Fournel

I

,

Dusuel

A

,

Rerole

AL

, et al.

Improved quantification of plasma lipopolysaccharide (LPS) burden in sepsis using 3-hydroxy myristate (3HM): a cohort study

.

Intensive Care Med

.

2019

;

45

(

11

):

1678

–

80

.

66.

Klein

DJ

,

Foster

D

,

Walker

PM

,

Bagshaw

SM

,

Mekonnen

H

,

Antonelli

M

.

Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial

.

Intensive Care Med

.

2018

;

44

(

12

):

2205

–

12

.

67.

Khoroshilov

SE

,

Nikulin

AV

,

Bessonov

IV

,

Morozov

AS

,

Yarema

IV

.

Efficacy and safety of a novel adsorber for LPS-selective hemosorption (experimental study)

.

Gen Reanimatology

.

2018

;

14

(

6

):

51

–

60

.

68.

Magomedov Mak

TG

,

Masolitin

SV

,

Yaralian

AV

,

Kalinin

EY

,

Pisarev

VM

.

Use of sorbent based on hypercrosslinked styrene-divinylbenzene copolymer with immobilized LPS-selective ligand in hemoperfusion for treatment of patients with septic shock

.

Gen Reanimatology

.

2020

;

16

(

6

):

31

–

53

.

69.

Rey

S

,

Kulabukhov

VM

,

Popov

A

,

Nikitina

O

,

Berdnikov

G

,

Magomedov

M

, et al.

Hemoperfusion using the lps-selective mesoporous polymeric adsorbent in septic shock: a multicenter randomized clinical trial

.

Shock

.

2023

;

59

(

6

):

846

–

54

.

70.

Broman

ME

,

Hansson

F

,

Vincent

JL

,

Bodelsson

M

.

Endotoxin and cytokine reducing properties of the oXiris membrane in patients with septic shock: a randomized crossover double-blind study

.

PLoS One

.

2019

;

14

(

8

):

e0220444

.

71.

Feng

J

,

Zhang

S

,

Ai

T

,

Wang

L

,

Gao

Y

,

Li

W

, et al.

Effect of CRRT with oXiris filter on hemodynamic instability in surgical septic shock with AKI: a pilot randomized controlled trial

.

Int J Artif Organs

.

2022

;

45

(

10

):

801

–

8

.

72.

Xie

J

,

Xiao

W

,

Lin

J

.

Effect of oXiris-CVVH on the clinical outcomes of patients with septic shock: an inverse probability of treatment-weighted analysis

.

Blood Purif

.

2022

;

51

(

12

):

972

–

89

.

73.

Kang

JH

,

Super

M

,

Yung

CW

,

Cooper

RM

,

Domansky

K

,

Graveline

AR

, et al.

An extracorporeal blood-cleansing device for sepsis therapy

.

Nat Med

.

2014

;

20

(

10

):

1211

–

6

.